지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 57 - 58 (2page)
이용수
초록· 키워드
오류제보하기
An accurate diagnostic marker for detecting early-stage hepatocellular carcinoma (eHCC) is clinically important, since early detection of HCC remarkably improves patient survival. From the integrative analysis of the transcriptome and clinicopathologic data of human multi-stage HCC tissues, we were able to identify barrier-to-autointegration factor 1 (BANF1), procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3) and splicing factor 3b subunit 4 (SF3B4) as early HCC biomarkers which could be detected in precancerous lesions of HCC, with superior capabilities to diagnose eHCC compared to the currently popular HCC diagnostic biomarkers: GPC3, GS, and HSP70. We then showed that SF3B4 knockdown caused G1/S cell cycle arrest by recovering p27kip1 and simultaneously suppressing cyclins, and CDKs in liver cancer cells. Notably, we demonstrated that aberrant SF3B4 overexpression altered the progress of splicing progress of the tumor suppressor gene, kruppel like factor 4 (KLF4), and resulted in non-functional skipped exon transcripts. This contributes to liver tumorigenesis via transcriptional inactivation of p27Kip1 and simultaneous activation of Slug genes. Our results suggest that SF3B4 indicates early-stage HCC in precancerous lesions, and also functions as an early-stage driver in the development of liver cancer.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Hepatocellular carcinoma: old friends and new tricks
Experimental and Molecular Medicine
2020 .12
-
Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples
BMB Reports
2022 .11
-
3D Structure Analysis Study of Hepatocellular Carcinoma (HCC) Biomarker NACA, NME2, PSMD4 for High Sensitivity HCC Diagnosis Sensor
한국생물공학회 학술대회
2015 .04
-
CDKN2 expression is a potential biomarker for T cell exhaustion in hepatocellular carcinoma
BMB Reports
2024 .06
-
From genome sequencing to the discovery of potential biomarkers in liver disease
BMB Reports
2020 .01
-
Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
BMB Reports
2018 .01
-
Combination of Image-guided Intervention and Functional Polymeric Microspheres for Effective Hepatocellular Carcinoma (HCC) Treatment
한국고분자학회 학술대회 연구논문 초록집
2018 .10
-
Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma
Experimental and Molecular Medicine
2020 .08
-
Mitochondrial defect-responsive gene signature in liver-cancer progression
BMB Reports
2015 .01
-
Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma
Experimental and Molecular Medicine
2022 .11
-
Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44
BMB Reports
2015 .01
-
Depletion of S100A4+ stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors
Experimental and Molecular Medicine
2018 .01
-
우리의 가까운 미래, SF 소설
지반(한국지반공학회지)
2018 .03
-
A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma
Experimental and Molecular Medicine
2018 .01
-
YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior
Experimental and Molecular Medicine
2021 .06
-
Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
Experimental and Molecular Medicine
2020 .01
-
Dynamic Optimization of the PWR SF Transportation With Constraints on Storage Capacity and SF Movement
한국방사성폐기물학회 학술대회
2018 .01
-
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging
Experimental and Molecular Medicine
2019 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0